Asma Tulbah Selected Research

5'- ((N- (2- decanoylamino- 3- hydroxy- 3- phenylpropyloxycarbonyl)glycyl)amino)- 5'- deoxyuridine (PP36)

4/2012

The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asma Tulbah Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2002
25	Neoplasms (Cancer) 11/2022 - 11/2007
4	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2002
4	Triple Negative Breast Neoplasms 01/2021 - 11/2019
3	Disease Progression 01/2021 - 01/2013
2	Carcinogenesis 01/2022 - 01/2019
1	Squamous Cell Carcinoma of Head and Neck 06/2019
1	Oropharyngeal Neoplasms 06/2019
1	Synovial Sarcoma (Synovioma) 03/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Obesity 09/2017
1	Vascular Neoplasms (Neoplasms, Vascular) 02/2014
1	Hypoxia (Hypoxemia) 12/2012
1	Prostatic Neoplasms (Prostate Cancer) 04/2011
1	Adenocarcinoma 04/2011
1	Hyperplasia 04/2011
1	Carcinoma (Carcinomatosis) 04/2011
1	Liver Neoplasms (Liver Cancer) 11/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2014
4	Phenobarbital (Luminal)FDA Link 01/2021 - 06/2013
3	Estrogen ReceptorsIBA 01/2021 - 08/2007
2	ParaffinIBA 06/2021 - 06/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2019
2	durvalumabIBA 01/2021 - 11/2019
2	fascinIBA 01/2019 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2010
2	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2017 - 12/2012
1	RNA (Ribonucleic Acid)IBA 11/2022
1	MethyltransferasesIBA 01/2022
1	Formaldehyde (Formol)FDA Link 06/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Cyclin D1IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	AntibodiesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	IntegrinsIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	reparixinIBA 01/2019
1	olaparibIBA 12/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2018
1	embelinIBA 12/2018
1	CateninsIBA 01/2018
1	TransferasesIBA 01/2018
1	LeptinIBA 09/2017
1	Anaplastic Lymphoma KinaseIBA 09/2015
1	VimentinIBA 08/2015
1	Messenger RNA (mRNA)IBA 08/2015
1	ClaudinsIBA 08/2015
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 06/2015
1	Capsules (Microcapsules)IBA 02/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Explosive Agents (Explosives)IBA 01/2014
1	Biological ProductsIBA 01/2013
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	TOR Serine-Threonine KinasesIBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012
1	matrigelIBA 12/2012
1	prolyl-proline (Pro-Pro)IBA 04/2012
1	5'- ((N- (2- decanoylamino- 3- hydroxy- 3- phenylpropyloxycarbonyl)glycyl)amino)- 5'- deoxyuridine (PP36)IBA 04/2012
1	arginylarginine (Arg-Arg)IBA 04/2012
1	Codon (Codons)IBA 04/2012
1	arginylprolineIBA 04/2012
1	Adenosine Triphosphate (ATP)IBA 04/2011
1	TubulinIBA 04/2011
1	DesminIBA 04/2011
1	Keratins (Keratin)IBA 04/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2011
1	Protein Disulfide-IsomerasesIBA 04/2011
1	Coenzyme A (CoA)IBA 04/2011
1	ProhibitinsIBA 04/2011
1	Hydro-Lyases (Dehydratases)IBA 04/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2011
1	NF-kappa B (NF-kB)IBA 01/2011
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2011
1	Metalloproteases (Metalloproteinases)IBA 01/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010
1	AnthracyclinesIBA 01/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2008
1	SurvivinIBA 04/2008
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2007
1	Progesterone FDA LinkGeneric 08/2007
1	Monoclonal AntibodiesIBA 03/2006

Therapy/Procedure

7	Therapeutics 01/2022 - 03/2011
4	Neoadjuvant Therapy 11/2022 - 10/2002
3	Immunotherapy 06/2021 - 02/2008
3	Drug Therapy (Chemotherapy) 11/2019 - 11/2002
1	Adjuvant Radiotherapy 03/2019
1	Liver Transplantation 11/2007